Bluebird bio Inc (NASDAQ: BLUE) is -52.01% lower on its value in year-to-date trading and has touched a low of $0.65 and a high of $5.53 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The BLUE stock was last observed hovering at around $0.69 in the last trading session, with the day’s loss setting it -0.03%.
Currently trading at $0.66, the stock is -35.17% and -34.97% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 7.1 million and changing -4.28% at the moment leaves the stock -56.75% off its SMA200. BLUE registered -81.13% loss for a year compared to 6-month gain of -39.79%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -41.90% loss in the last 1 month and extending the period to 3 months gives it a -35.70%, and is -37.52% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 14.79% over the week and 11.30% over the month.
Profit margin for the company is -419.62%. Distance from 52-week low is 1.89% and -88.02% from its 52-week high. The company has generated returns on investments over the last 12 months (-20.06%).
with sales reaching $9.66M over the same period.The EPS is expected to grow by 11.73% this year, but quarterly earnings will post 798.50% year-over-year. Quarterly sales are estimated to grow 15,480.60% in year-over-year returns.
Bluebird bio Inc (BLUE) Top Institutional Holders
208.0 institutions hold shares in Bluebird bio Inc (BLUE), with institutional investors hold 44.36% of the company’s shares. The shares outstanding are 192.74M, and float is at 191.55M with Short Float at 16.25%. Institutions hold 44.20% of the Float.
The top institutional shareholder in the company is BLACKROCK INC. with over 15.18 million shares valued at $19.43 million. The investor’s holdings represent 13.9128 of the BLUE Shares outstanding. As of 2024-03-31, the second largest holder is VANGUARD GROUP INC with 10.5 million shares valued at $13.44 million to account for 9.623 of the shares outstanding. The other top investors are GRANAHAN INVESTMENT MANAGEMENT, LLC which holds 7.71 million shares representing 7.0686 and valued at over $9.87 million, while AMERIPRISE FINANCIAL INC holds 5.8591 of the shares totaling 6.39 million with a market value of $8.18 million.
Bluebird bio Inc (BLUE) Insider Activity
The most recent transaction is an insider sale by Klima Thomas J. SEC filings show that Klima Thomas J sold 3,834 shares of the company’s common stock on Jun 03 ’24 at a price of $0.97 per share for a total of $3726.0. Following the sale, the insider now owns 0.12 million shares.
Bluebird bio Inc disclosed in a document filed with the SEC on Mar 01 ’24 that Colvin Richard A (Chief Medical Officer) sold a total of 6,770 shares of the company’s common stock. The trade occurred on Mar 01 ’24 and was made at $1.53 per share for $10342.0. Following the transaction, the insider now directly holds 0.12 million shares of the BLUE stock.
Still, SEC filings show that on Mar 04 ’24, Obenshain Andrew (President and CEO) disposed off 6,095 shares at an average price of $1.53 for $9311.0. The insider now directly holds 279,998 shares of Bluebird bio Inc (BLUE).
